⌘K
Loading ticker…
Relmada Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Relmada Therapeutics, Inc. Common Stock (RLMD) has a 3-month relative strength percentile of 46 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 99. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 9.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
46 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RLMD is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $15M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $15M |
| VXFVanguard Extended Market ETF | 0.01% | $6M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RLMD Jan avg: -12.03% median: -15.79% win: 25% σ: 22.34% n: 4 2022-04-12 → 2026-05-29 | RLMD Feb avg: 11.87% median: 8.56% win: 50% σ: 37.17% n: 4 2022-04-12 → 2026-05-29 | RLMD Mar avg: -1.21% median: -10.12% win: 50% σ: 39.77% n: 4 2022-04-12 → 2026-05-29 | RLMD Apr avg: 3.22% median: 8.05% win: 60% σ: 15.77% n: 5 2022-04-12 → 2026-05-29 | RLMD May avg: 19.69% median: -4.12% win: 40% σ: 64.75% n: 5 2022-04-12 → 2026-05-29 | RLMD Jun avg: -8.07% median: -6.69% win: 50% σ: 10.30% n: 4 2022-04-12 → 2026-05-29 (current) | RLMD Jul avg: 16.75% median: 14.25% win: 100% σ: 14.49% n: 4 2022-04-12 → 2026-05-29 | RLMD Aug avg: 24.82% median: 21.42% win: 75% σ: 42.86% n: 4 2022-04-12 → 2026-05-29 | RLMD Sep avg: 27.74% median: 21.38% win: 75% σ: 38.04% n: 4 2022-04-12 → 2026-05-29 | RLMD Oct avg: -15.81% median: 3.54% win: 50% σ: 44.93% n: 4 2022-04-12 → 2026-05-29 | RLMD Nov avg: 10.43% median: -15.30% win: 25% σ: 59.71% n: 4 2022-04-12 → 2026-05-29 | RLMD Dec avg: -8.25% median: -8.92% win: 50% σ: 62.78% n: 4 2022-04-12 → 2026-05-29 |